Metal–Organic Framework Nanomaterials as a Medicine for Catalytic Tumor Therapy: Recent Advances

13Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Nanomaterials, with unique physical, chemical, and biocompatible properties, have attracted significant attention as an emerging active platform in cancer diagnosis and treatment. Amongst them, metal–organic framework (MOF) nanostructures are particularly promising as a nanomedicine due to their exceptional surface functionalities, adsorption properties, and organo-inorganic hybrid characteristics. Furthermore, when bioactive substances are integrated into the structure of MOFs, these materials can be used as anti-tumor agents with superior performance compared to traditional nanomaterials. In this review, we highlight the most recent advances in MOFs-based materials for tumor therapy, including their application in cancer treatment and the underlying mechanisms.

Cite

CITATION STYLE

APA

Zhang, J., Li, M., Liu, M., Yu, Q., Ge, D., & Zhang, J. (2024, May 1). Metal–Organic Framework Nanomaterials as a Medicine for Catalytic Tumor Therapy: Recent Advances. Nanomaterials. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/nano14090797

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free